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The efficacy of metoclopramide for preventing organo-
phosphate insecticide-induced (diazinon) toxicosis was
evaluated in 7~14 days old chicks. Injection of metoclo-
pramide at 25 mg/kg, s.c. 15 min before diazinon increased
the oral 24 h median lethal dose of the insecticide in the
chicks by 80%. Metoclopramide alone inhibited the  in
vitro and in vivo plasma and whole brain cholinesterase
activities of the chicks. Metoclopramide pretreatment at
100 mg/kg, s.c. reduced the extent of cholinesterase
inhibition that was caused by diazinon (10 mg/kg, p.o.) in
the plasma and whole brain by 24% and 7%, respectively.
Diazinon at 10 mg/kg, p.o. produced signs of cholinergic
toxicosis in the chicks, and these signs included salivation,
lacrimation, gasping and convulsions within 2 h, and the
2-h and 24-h lethalities were 88 and 100%, respectively.
Metoclopramide at the dose rates of 12.5, 25, 50, 100 and
200 mg/kg, s.c. given 15 min before diazinon (10 mg/kg,
p.o.) variably decreased the occurrence of toxic manifestations
in the chicks. The highest dose of metoclopramide (200
mg/kg, s.c.) reduced the 2-h and 24-h lethality of diazinon
to 75% each and it reduced the overall toxicity score of
diazinon by 32%. The data suggest that metoclopramide
pretreatment only partially protected chicks against the
acute toxicity of diazinon.
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Introduction
Organophosphates are widely used as insecticides in
public health, veterinary practice and agriculture [8,15,28].
The single most important mechanism of the toxic action of
these insecticides in man and animals is inhibition of
acetylcholinesterase at the nerve terminals, and this causes
acetylcholine accumulation that subsequently causes a series
of muscarinic, nicotinic and central nervous system effects
[4,16,26]. The cardinal treatment for organophosphate
poisoning includes atropine to counteract the muscarinic
signs and symptoms, and oximes to reactivate the inhibited
cholinesterases [4,16,26,28]. However, the clinical results of
administering antidotal therapy for organophosphate poisoning
are far from perfect [4,6,16,26,28], and there are many
ongoing experimental trials using other therapeutic and
protective agents for controlling the signs and symptoms of
poisoning, and especially those related to the nicotinic
effects that are not controlled by atropine. Examples of such
trials include antihistamine diphenhydramine [5,12], alpha-
2-adrenoceptor agonists [7,29] and metoclopramide, which
is a dopamine D2 receptor antagonist [14,22-24].
Metoclopramide is used clinically as a prokinetic and
antiemetic agent [25]. Other than the antidopaminergic and
possible serotonergic effects, metoclopramide has been
found to possess anticholinesterase properties [13,14,22-24].
The drug weakly inhibits cholinesterase activity both in vitro
[22,23] and in vivo [14,24], and so it supposedly prevents
further enzyme inhibition by organophosphate compounds.
This protective effect of metoclopramide on the cholinesterase
is thought to be of practical usefulness for the treatment of
organophosphate poisoning [22,23]. Further in vivo protection
studies in rats that were poisoned by the organophosphate
paraoxon demonstrated that metoclopramide was less effective
as a protective agent than pralidoxime, without taking into
consideration the possible effects of metoclopramide on the
signs of poisoning [14,24].
Other than preventing additional cholinesterase inhibition,
it is not known whether metoclopramide can modify the
signs and symptoms of acute organophosphate poisoning in
experimental animals. The aim of the present study was to
evaluate the protective effect of metoclopramide in a chick
model of acute diazinon-induced toxicosis. Diazinon is an
organophosphate insecticide that’s widely used in veterinary
medicine [1].
Materials and Methods
Seven to fourteen days old, mixed breed broiler chicks of
either sex (52-95 grams each) were used in the experiments.
They were maintained in batches of 20-30 chicks in a room
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with constant lighting at a temperature of 30-34
oC, which
was controlled by electric heaters. The floor litter consisted
of wood shavings. Water and feed were given ad libitum.
Metoclopramide HCl (Yuhan, Korea) was dissolved in
physiological saline solution for s.c. administration at a
volume of 5 ml/kg body weight [3]. A commercial insecticidal
concentrated solution of diazinon (60%; Novartis, Switzerland)
was further diluted in distilled water to obtain the desired
concentrations of the insecticide for oral dosing, at a volume
of 5 ml/kg body weight, by using a gavage needle. The
choices of the metoclopramide and diazinon doses were
based on our preliminary experiments on chicks, as well as
on a previous study [3].
The acute (24 h) median lethal doses (LD50) of diazinon
with or without metoclopramide (25 mg/kg, s.c., 15 min
before diazinon dosing) were determined in the chicks by
the up-and-down method [10]. The chicks were individually
observed for the appearance of signs of toxicosis for 1 h and
then the 24 h lethality was recorded. The protective ratio for
metoclopramide was calculated as follows:
Protective ratio = LD50 of diazinon with metoclopramide/
LD50 of diazinon with saline
In vitro cholinesterase inhibition
Six chicks were killed by decapitation after performing
ether anesthesia, and blood samples were collected using
heparinized test tubes [9]. The plasma was separated from
the erythrocytes by centrifugation at 3,000 rpm (Centurion,
UK) for 15 min. The whole brains were also obtained from
the chicks. All the samples were kept at –20ºC pending
cholinesterase analysis that was done within one week. The
whole brain was homogenized on an ice bath by using a
glass homogenizer with phosphate barbital buffer (pH 8.1)
at 3 ml/100 mg wet weight [17,20]. Samples of the plasma
and brain homogenates were separately pooled. The inhibitor-
cholinesterase incubation method was used to cause in vitro
inhibition of cholinesterase activities by metoclopramide in
aliquots of the pooled plasma and the brain homogenates as
has been described before [18,19]. The desired concentrations
of metoclopramide were prepared in distilled water and then
individually added, in a volume of 0.1 ml, to the enzymatic
reaction mixtures of the plasma or brain homogenate (5
samples/concentration). The final concentrations of
metoclopramide in the reaction mixtures were 9.4, 18.8,
37.5 and 75 µM, respectively. The control reaction mixtures
did not contain metoclopramide and they were used for
measurement of the baseline cholinesterase activities in the
plasma and brain samples. The reaction mixtures containing
metoclopramide were initially incubated at 37
oC for 10 min
to facilitate cholinesterase inhibition [18,19].
 Thereafter, the
residual cholinesterase activity (∆pH/30 min) in the mixtures
was measured by an electrometric method that’s been
described earlier (17-19]. The % of cholinesterase inhibition
was calculated as follows:
% Cholinesterase inhibition =
[Cholinesterase activity (without metoclopramide) −
Cholinesterase activity (with metoclopramide)/Cholinesterase
activity (without metoclopramide)] × 100
In vivo effect of metoclopramide on cholinesterase activity
Eighteen chicks were randomly divided into 3 groups of 6
birds each. The chicks were treated with either the
physiological saline solution at 5 ml/kg, s.c. (the control) or
with metoclopramide at 100 or 200 mg/kg, s.c., respectively.
Thirty minutes after the metoclopramide treatment, the
chicks were euthanized to obtain the plasma and whole
brain for determining the cholinesterase activity [17-19].
The choices of the metoclopramide doses and the time of
obtaining the samples depended on a previous finding in
which the pharmacological effects of metoclopramide appeared
in the chicks within 30 min after s.c. injection [3].
In another experiment, chicks (6/group) were treated with
the physiological saline solution at 5 ml/kg, s.c. (the control)
or with metoclopramide at 100 mg/kg, s.c. 15 min before an
oral dosing with diazinon at 10 mg/kg. The experiment also
included a control group that was not subjected to diazinon
or metoclopramide treatments. Thirty minutes after the
administration of diazinon, the chicks were euthanized to
obtain their plasma and whole brain for determining the
cholinesterase activity, as was described earlier.
Effect of metoclopramide on diazinon-induced toxicosis
Chicks (8/group) were treated s.c. with the physiological
saline solution at 5 ml/kg (the control) or with metoclopramide
at dose rates of 12.5, 25, 50, 100 or 200 mg/kg of body
weight, respectively. Fifteen minutes after injection, all the
chicks were dosed orally with diazinon at 10 mg/kg of body
weight. The choice of the metoclopramide doses depended
on a previous study that reported the pharmacological
effects of the drug on chicks [3]. The dose of diazinon (10
mg/kg) was determined in a preliminary experiment on
chicks, and this dose was found to induce death in 80 to
100% of the dosed chicks within 24 h. After the diazinon
dosing, the chicks were observed individually for the
occurrence of the signs of organophosphate poisoning that
are characteristic of cholinergic toxicity [11,12,17]. The
signs included salivation, lacrimation, gasping and convulsion.
The 2-h and 24-h lethalities were also recorded. The
latencies to onset of any sign of poisoning and death were
recorded within 2 h. The severity of toxicosis within each
treatment group was scored as has been described before
[2]. The following grades were assigned to the percentage of
occurrence of the signs of poisoning (salivation, lacrimation,
gasping and convulsions), including the 2-h and 24-h
lethalities: Grade 1 (1~25%), Grade 2 (26~50%), Grade 3
(51~75%) and Grade 4 (76~100%).
For reference, the highest toxicity score within a group
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gasping and convulsions) and the 2-h and 24-h lethalities
would be 24 (4 × 6 signs or death with 100% occurrence).
The present study was approved by the Scientific
Committee of the College of Veterinary Medicine at the
University of Mosul (Iraq). All the experiments complied
with regulations addressing animal use, and proper attention
and care was given to the chicks used in this study.
Statistics
The data as multiple means were subjected to the analysis
of variance followed by the least significant difference test
[21]. The frequency data were subjected to the Fisher’s
exact probability test, and the scores of the severity of
toxicosis were analyzed by the Wilcoxon signed rank test
[21]. The level of statistical significance was p < 0.05.
Results
The acute (24 h) oral LD50 value of diazinon alone in the
chicks was 9.2 mg/kg (Table 1). The signs of cholinergic
toxicosis in the chicks appeared within 11-42 min. The signs
were salivation, lacrimation, gasping, frequent defecation,
convulsions and recumbency before death. Injection of
metoclopramide at 25 mg/kg, s.c. increased the oral LD50
value of diazinon by 80% to 16.53 mg/kg, with a protective
ratio of 1.8 (Table 1).
Metoclopramide, in a concentration-dependent manner
(9.4~75 µM), inhibited the in vitro plasma and whole brain
cholinesterase activities by 3-28% and 2-19%, respectively
(Table 2). Subcutaneous injection of metoclopramide at 100
and 200 mg/kg dose-dependently reduced the plasma (11%
Table 1. Determination of the 24-h median lethal dose (LD50) of diazinon alone or in combination with metoclopramide in chicks by
the up-and-down method*
Variable Result
Diazinon alone (saline pretreatment) 
LD50 9.20 mg/kg, p.o.
Range of the doses used 15~10 = 5 mg/kg, p.o.
Initial dose 15 mg/kg, p.o.
Last dose 10 mg/kg, p.o.
Number of chicks used  6 (XXOXOO)
Increase or decrease in dose 5 mg/kg, p.o.
Range of latency to the onset of poisoning  42~11 = 31 min
Signs of poisoning salivation, lacrimation, gasping, frequent defecation, 
convulsions and recumbency
Diazinon with metoclopramide pretreatment
LD50 16.53 mg/kg, p.o.
Range of the doses used 20~10 = 10 mg/kg, p.o.
Initial dose 15 mg/kg, p.o.
Last dose 15 mg/kg, p.o.
Number of chicks used  5 (OXXOO)
Increase or decrease in dose 5 mg/kg, p.o.
Range of latency to the onset of poisoning  53~22 = 31 min
Signs of poisoning salivation, lacrimation, gasping, frequent defecation, 
convulsions and recumbency
X=d e a t h ;  O=s u r v i v a l .
*Metoclopramide was injected 15 min before the diazinon dosing.
Table 2. In vitro inhibition of the plasma and whole brain cholinesterase activities in chicks by metoclopramide
Metoclopramide 
concentration (µM)
Plasma Whole brain
∆pH/30 min % inhibition ∆pH/30 min % inhibition
0 (baseline) 0.32 ± 0.018 0.180 ± 0.010
9.4 0.31 ± 0.030 3 0.177 ± 0.002 2
18.8 0.30 ± 0.020 6 0.173 ± 0.005 4
37.5 0.27 ± 0.010 16 0.160 ± 0.005 11
75 0.23 ± 0.010* 28 0.145 ± 0.005* 19
Cholinesterase activity values are mean ± SE, n = 5/each concentration.
*Significantly different from the respective baseline value ( p <0 . 0 5 ) .252 M. H. I. Al-Zubaidy, F. K. Mohammad
and 47%) and whole brain (19% and 44%) cholinesterase
activities of the chicks in comparison with the control values
(Table 3). The metoclopramide-treated chicks appeared sedated
as they manifested drooping of the neck, immobility, closed
eyelids, decreased distress squeaks and recumbency.
Dosing the chicks orally with diazinon at 10 mg/kg
significantly inhibited the plasma cholinesterase activity by
79% and this inhibited the cholinesterase activity of the
whole brain by 20%, although this was non-significant
(Table 4). Metoclopramide pretreatment at 100 mg/kg, s.c.
reduced the degree of cholinesterase inhibition caused by
diazinon (10 mg/kg, p.o.) in the plasma and whole brain to
55% and 13%, respectively (Table 4).
Diazinon at 10 mg/kg, p.o. produced signs of cholinergic
toxicosis in the chicks, and this included salivation,
lacrimation, gasping and convulsions within 2 h, and the 2-h
and 24-h lethalities were 88% and 100%, respectively
(Table 5). Metoclopramide at the dose rates of 12.5-200 mg/
kg, s.c. and given 15 min before diazinon (10 mg/kg, p.o.)
variably decreased the occurrence of toxic manifestations in the
chicks (Table 5). The highest dose of metoclopramide
(200 mg/kg, s.c.) reduced the 2-h and 24-h lethalities from
88% and 100%, respectively, in the control group (diazinon
only) to 75% each (Table 5). Correspondingly, all the
metoclopramide-treated groups had low overall toxicity
scores, and the highest dose of metoclopramide significantly
reduced the score by 32% in comparison with the control
group (diazinon only) (Fig. 1). Metoclopramide treatments
did not significantly affect the latencies to the onset of signs
of poisoning and the lethalities induced by diazinon (data
not shown).
Discussion
Metoclopramide pretreatment reduced the diazinon-
induced lethality in chicks, as was determined by the LD50
values, with a protective ratio of 1.8. This finding in a chick
model of acute organophosphate poisoning confirms an
Table 3. In vivo inhibition of the plasma and whole brain cholinesterase activities in chicks by metoclopramide
Metoclopramide
(mg/kg, s.c.)
Plasma Whole brain
∆pH/30 min % inhibition ∆pH/30 min % inhibition
0 (saline-control) 0.45 ± 0.050 0.16 ± 0.01
100 0.40 ± 0.050 11 0.13 ± 0.01 19
200 0.24 ± 0.020*
,† 47 0.09 ± 0.01*
,† 44
Cholinesterase activity values are means ± SE, n = 6 chicks/group. Cholinesterase activity was determined 30 min after the metoclopramide injection. 
*Significantly different from the respective control value ( p <0 . 0 5 ) .
†Significantly different from the respective value of the 100 mg/kg dose group of metoclopramide ( p <0 . 0 5 ) .
Table 4. Effect of metoclopramide on the plasma and whole brain cholinesterase activities in the diazinon-treated chicks
Treatment
Plasma Whole brain
∆pH/30 min % inhibition ∆pH/30 min % inhibition
Saline (control) 0.33 ± 0.05 0.15 ± 0.02
Diazinon 0.07 ± 0.02* 79 0.12 ± 0.01 20
Metoclopramide + Diazinon 0.15 ± 0.02*
,† 55 0.13 ± 0.01 13
Cholinesterase activity values are means ± SE, n = 6 chicks/group. Metoclopramide was injected 15 min (100 mg/kg, s.c.) before the diazinon dosing.
Cholinesterase activity was determined 30 min after the diazinon dosing (10 mg/kg, p.o.).
*Significantly different from the respective control value ( p <0 . 0 5 ) .
†Significantly different from the respective value of the diazinon-treated group ( p <0 . 0 5 ) .
Table 5. Effect of metoclopramide treatment on diazinon-induced toxicosis in chicks*
Metoclopramide 
(mg/kg, s.c.)
Occurrence rate (%)
Salivation Lacrimation Gasping Convulsions 2 h death 24 h death
0 (saline control) 88 63 63 88 88 100
1 2 . 5 7 51 36 38 88 88 8
25 88 13 25 100 100 100
50 75 25 88 100 100 100
100 63 25 63 88 88 88
200 75 25 50 75 75 75
*Metoclopramide was injected 15 min before the diazinon dosing (10 mg/kg, p.o.). n = 8 chicks/group.Metoclopramide protection of diazinon-induced toxicosis in chickens 253
earlier suggestion concerning the protective benefit of
metoclopramide against organophosphate poisoning [22,23].
The mechanism of such a protective effect has been
suggested to be associated with an inhibiting action of
metoclopramide on the target cholinesterases in the nervous
tissues, thus preventing further inhibition by the organophosphate
[14,22,23]. Our in vitro and in vivo experiments on
metoclopramide inhibition of the plasma and whole brain
cholinesterase activities further support and expand the
previous findings on the cholinesterase inhibitory benefits of
metoclopramide, as was demonstrated in rats [14,23,24].
In this study, metoclopramide pretreatment reduced the
cholinesterase inhibitory effects of diazinon by 24% in the
plasma and by 7% in the whole brain. This finding supports
the notion that the protective effect of metoclopramide on
the cholinesterases could potentially contribute to the protective
benefit of this drug against organophosphate poisoning
[14,23,24]. Further, the protective benefit of metoclopramide
appeared to also include the whole brain of the chicks. Nerve
tissues, including the brain, are the main targets affected by
organophosphate poisoning [4,16,26,28]. Organophosphates
inhibit cholinesterase activity and cause accumulation of
acetylcholine at the nerve endings and they subsequently
induce cholinergic overstimulation that’s manifested as
muscarinic, nicotinic and central nervous system effects
such as convulsions [4,16,26,28].
Diazinon at a dose of 10 mg/kg, p.o., which is close to its
LD50 value, produced as expected signs and symptoms of
organophosphate poisoning in the chicks along with
inhibitory effects on the plasma and whole brain cholinesterases.
However, as metoclopramide incompletely protected the
enzyme, the drug only partially reduced the occurrence of
signs of diazinon toxicosis as well as reducing lethality in
the chicks. The single treatment with metoclopramide and
its partial effectiveness suggest a need for reevaluating the
protective effect of metoclopramide against organophosphate
poisoning. Multiple metoclopramide pretreatments might
also be taken into consideration.
The chicks treated with metoclopramide were found to be
sedated as they manifested drooping of the head, immobility,
closed eyelids, decreased distress squeaks and recumbency.
Metoclopramide sedation in chicks has been recently
reported [3] and the contribution of this sedation to the
protective effect of the drug against diazinon-induced
poisoning is not clear at the present time. The sedative effect
of metoclopramide is probably not related to its
anticholinesterase effect, as the drug is a dopamine D2-
receptor antagonist [25]. Antidopaminergic drugs produce a
state of sedation and tranquilization in birds and mammals
[1,27].
In conclusion, metoclopramide was found to partially
protect chicks against the acute toxicity of diazinon. Further
studies are needed on the protective effect of metoclopramide
against poisoning induced by other organophosphate insecticides.
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